Listed
Stock Code: 023910
| Company Name | 대한약품공업(주) |
| English Name | DaehanPharmaceutical |
| Business Reg. No. | 1078134737 |
| CEO | 이승영 |
| Address | 서울특별시 영등포구 선유로45길 3 |
| Industry | 의약품 제조업 |
| Industry Code | 212 |
| Established | 19630511 |
| Phone | 02-2678-8443 |
| Website | www.daihan.com |
| Regular Employees | 750persons |
| Corp. Reg. No. | 1101110080484 |
Revenue CAGR +6.0%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 2,042B | 1,959B | 1,843B | 1,715B |
| Operating Profit | 381B | 358B | 330B | 291B |
| Net Profit | 338B | 284B | 250B | 227B |
| Total Assets | 3,244B | 2,943B | 2,770B | 2,725B |
| Total Liabilities | 484B | 463B | 516B | 697B |
| Total Equity | 2,760B | 2,480B | 2,254B | 2,028B |
▲ 11.0%
▲ 16.8%
▲ 5.3%
▼ 30.7%
▲ 8.8%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 이윤우 | 사내이사 | 경 영 | - |
| 이동일 | 사내이사 | 영 업 | - |
| 이승영 | 사내이사 | 경 영 | - |
| 박환석 | 사외이사 | 사외이사 | - |
| 김광희 | 감사 | 감 사 | - |
| 박영대 | 미등기 | 생 산 | - |
| 임방호 | 미등기 | 품질관리 | - |
| 오창민 | 미등기 | 자 금 | - |
| 조영기 | 미등기 | 회 계 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 679persons |
| CEO | 이승영 |
| Est. Avg. Annual Salary | 5,61910K (46810K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -3persons |
| Net Change (12 mo) | -2persons |
| NPS Join Date | 1988-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
1 Additional Data Sources
{
"address": "서울특별시 영등포구 선유로45길",
"brno": "107813****",
"cappedWarning": false,
"companyName": "대한약품공업(주)",
"estimatedAvgAnnualSalary": 56185068,
"estimatedAvgMonthlySalary": 4682089,
"fetchedAt": "2026-02-27T23:42:17.760Z",
"industryCode": "242301",
"industryName": "완제 의약품 제조업",
"joinDate": "19880101",
"last12MonthsHired": 1,
"last12MonthsLeft": 3,
"last12MonthsNetChange": -2,
"leaveDate": null,
"monthlyPensionAmount": 302018180,
"monthlyTrend": [
{
"lostSubscribers": 3,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6332722",
"status": "1",
"styleCode": "1",
"subscriberCount": 679,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 7/7
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-02-27 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |